hydroxylamine has been researched along with 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beranova, P; Boucher, JL; Chalupsky, K; Kleschyov, AL; Mansuy, D; Muller, B; Munzel, T; Schott, C; Stoclet, JC | 1 |
1 other study(ies) available for hydroxylamine and 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide
Article | Year |
---|---|
Nomega-hydroxy-L-arginine homologues and hydroxylamine as nitric oxide-dependent vasorelaxant agents.
Topics: Animals; Aorta, Thoracic; Arginine; Cyclic GMP; Cyclic N-Oxides; Dose-Response Relationship, Drug; Electron Spin Resonance Spectroscopy; Endothelium, Vascular; Enzyme Inhibitors; Guanylate Cyclase; Hydroxylamine; Imidazoles; In Vitro Techniques; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxadiazoles; Quinoxalines; Rats; Rats, Wistar; Signal Transduction; Vasodilation; Vasodilator Agents | 2005 |